No answer available

No answer available

A »When seeking contract manufacturers in London that specialize in over-the-counter (OTC) pharmaceutical production for the UK market, it is essential to recognize that the capital hosts a concentrated cluster of organizations offering end-to-end services aligned with the Medicines and Healthcare products Regulatory Agency (MHRA) standards and the Human Medicines Regulations 2012. Although many large-scale contract manufacturing organizations (CMOs) operate across the United Kingdom, a select number maintain dedicated facilities within the Greater London area or its immediate commuter belt, providing integrated capabilities from formulation development to packaging and distribution. One prominent entity is Pharmaceutics Ltd, a London-based CMO with decades of experience in OTC products such as analgesics, cough and cold remedies, and antacids; they offer full MHRA-licensed manufacturing, stability testing, and blister packaging, with a specific focus on the unique requirements of the UK retail pharmacy and grocery channels. Another key player is Sterling Pharmaceutical Services, located in Surrey but with a strong London-centric operational presence, which provides specialized OTC manufacturing including controlled-release formats and paediatric formulations; their services encompass granulation, compression, film-coating, and bottle filling, all under Good Manufacturing Practice (GMP) compliance as mandated by the MHRA. Additionally, companies like Recipharm (with a facility in the London area) and Delpharm (which has UK operations) offer flexible capacity for OTC liquid and semi-solid production, including suspensions and creams for external OTC use, while supporting importation and batch release for the UK market. The regulatory environment demands that any CMO serving the UK OTC sector must hold a manufacturer’s licence, comply with the British Pharmacopoeia, and demonstrate robust quality management systems; London-based manufacturers often also offer value-added services such as artwork design for patient information leaflets (PILs) and compliance with the Falsified Medicines Directive for serialization—critical for products sold through UK pharmacies and supermarkets. Furthermore, these manufacturers typically leverage proximity to distribution hubs and retail headquarters, facilitating efficient logistics for fast-moving stock-keeping units (SKUs). However, given the dynamic nature of contract manufacturing partnerships, it is advisable for clients to conduct due diligence on each candidate’s specific MHRA site registration, capacity for handling monographs based on traditional herbal registration (THR) if applicable, and experience with the rapidly evolving UK OTC market, including the shift toward sustainability in packaging and the rise of digital health integrated labelling. In summary, while London does not host the sheer volume of pharmaceutical manufacturing found in other UK regions, a specialized cohort of CMOs exists that provides tailored OTC production services, combining regulatory expertise with market-ready flexibility for brands seeking to launch or expand within the UK’s competitive self-care landscape.

A »Great question! Finding contract manufacturers specifically *in London* for OTC pharmaceuticals is a bit tricky, because the city's high real estate costs mean most large-scale production happens outside the M25. However, several UK-based CMOs (Contract Manufacturing Organisations) that serve the OTC market operate within easy reach, such as **Recipharm** (which has a London-area site for development and small-scale work) and **Sterling Pharma Solutions** (though their main plants are up north, they support OTC products). For full commercial OTC production, I'd suggest looking at broader UK specialists